Skip to content
Recall Observatory FDA recall evidence

Drug product

Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

D-0874-2022

April 22, 2022

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 90064
Status
Terminated
Classification
Class II
Quantity
8346 bottles
Official record key
drug-enforcement:D-0874-2022

Official wording

Reason: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Code information: Lots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations